# Ernexa Therapeutics Inc.: Form 10-K/A for the period ended Dec 31, 2023

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 10-K/A
- Filed: 2024-03-18
- Accepted by EDGAR: Mar 18, 2024, 07:30 ET
- Period: 2023-12-31
- Accession: 0001140361-24-013709
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036124013709/ef20024302_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036124013709/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036124013709/ef20024302_10ka.htm

Filed Mar 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-013709. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.